Aesthetic lasers are non-surgical, non-invasive procedures that are safe and effective for most skin types and skin tones. It involves the utilization of specific wavelengths of light to target and treat various skin concerns, such as wrinkles, scars, pigmentation issues, hair removal, and tattoo removal. Aesthetic lasers are designed to deliver controlled and precise energy to the skin, promoting collagen production and skin rejuvenation, resulting in improved skin texture and appearance.

Acute respiratory distress syndrome (ARDS) is a severe and life-threatening form of acute respiratory failure characterized by sudden and rapid onset of widespread inflammation in the lungs, leading to compromised oxygenation and respiratory function. ARDS typically occurs in response to various direct or indirect lung injuries, such as pneumonia, sepsis, trauma, aspiration of gastric contents, or inhalation injury, triggering an exaggerated inflammatory response and disruption of the alveolar-capillary barrier.

Bispecific antibodies for cancer are artificial proteins that simultaneously target two or more tumor antigens on the same or separate cells to interrupt cancer progression. They can simultaneously block two different pathways that employ unique pathogenesis.

Biosimilars are highly similar versions of biological drugs derived from living microorganisms found in plant or animal cells. They are nearly identical in structure and function to an original biological drug.

Biopharmaceutical analytical testing services include analytical laboratory testing that is focused on the selection of package and delivery systems to advance early-stage drug products through the development process.

Various CNS stimulants, such as lisdexamfetamine, methamphetamine, amphetamine, and armodafinil, are used to treat CNS disorders and their symptoms. These stimulants act by increasing the dopamine level in the brain, which increases blood pressure and heart rate.

Chronic disease management refers to the use of tools and software to manage the symptoms of long-term illnesses and improve monitoring chronic conditions, ensuring the well-being and safety of individuals.

1月31日，艾伯维公布了2024年业绩，全年总营收563.34亿美元，同比增长3.7%。研发投入为127.91亿美元，同比增长66.7%。艾伯维将2027年Skyriz和Rinvoq合并销售预期上调至超过270亿美元，其中Skyriz销售额预计超过170亿美元，Rinvoq销售额预计超过100亿美元。 

遮蔽技术（遮蔽肽/空间位阻遮蔽等）是近年免疫疗法中的热点领域，其是一种应对靶向性和非靶向性细胞毒性的解决策略。从早期临床结果来看，这一技术能够降低抗体类药物的不良反应，不仅能够增加现有药物的治疗窗，减毒增效；更能给未成药靶点带去成药曙光。关键点在于：遮蔽肽可以提升药物给药剂量。

脑机接口在医疗领域具有发展潜力：脑机接口（Brain-Computer Interface， BCI）技术是一种通过解读大脑信号来控制外部设备的技术，可以直接从大脑获取信息并将其转换为可操作的指令。在医疗保健领域，BCI 可以显著改善患有严重运动障碍或其他神经系统疾病患者的生活质量，具有极大的发展潜力。